Table 1. Patient demographics.
| Patient Demographics | |
| N = 416 | |
| Age (years) | 64±12 |
| Gender (male) n (%) | 318 (76) |
| Risk factors/past medical history n (%) | |
| Body mass index (BMI; mean±SD) | 28.1±5.5 |
| Hypertension | 352 (84) |
| Hyperlipidemia | 318 (76) |
| Smoking | 230 (55) |
| Family history of CAD | 129 (31) |
| Diabetes mellitus | 135 (32) |
| Prior PCI | 197 (47) |
| Prior myocardial infarction | 135 (31) |
| Peripheral arterial occlusive disease | 54 (13) |
| Cerebrovascular disease | 41(10) |
| Laboratory data (mean±SD) | |
| White blood cell count (WBC; ×109/L) | 7.9±2.6 |
| Platelets (x109/L) | 224±71 |
| C reactive protein (mg/dl) | 1.3±1.2 |
| Hemoglobin (g/dl) | 13.3±1.9 |
| Fibrinogen (mg/dl) | 413±119 |
| Creatinine (mg/dl) | 1.3±0.9 |
| Medication n (%) | |
| Aspirin | 416 (100) |
| Clopidogrel | 416 (100) |
| Proton pump Inhibitors (PPI) | 317 (76) |
| β blockers | 309 (74) |
| Angiotensin converting enzyme inhibitors (ACE) | 219 (53) |
| Statins | 303 (73) |
| Calcium channel blockers (CCB) | 80 (19) |
| PCI data | |
| Elective PCI | 274 (66) |
| PCI due to an acute coronary syndrome (ACS) | 140 (34) |
| NSTE-ACS | 67 (16) |
| STEMI | 73 (18) |
| Number of stents per patient | 1.7±1 |
| Total stent length | 31.8±21.7 |
| CYP2C19*2 carrier status n (%) | 126 (30) |
| CYP2C19*17 carrier status n (%) | 165 (40) |
| ABCB1 carrier status n (%) | 323 (77) |
| PON1 carrier status n (%) | 210 (50) |
Data are reported as Mean ± standard deviation (SD), n (number of patients) or percentages; CAD: coronary artery disease; PCI: percutaneous coronary intervention; NSTE-ACS: non ST- elevation acute coronary syndrome, STEMI: ST- elevation myocardial infarction. ABCB1: gene encoding transmembrane transporter P-glycoprotein; PON1: paroxonase 1.